No photo of Elena Tagliaferri

View Scopus Profile

Elena Tagliaferri

  • 370 Citations
  • 10 h-Index
19952019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Elena Tagliaferri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Transplants Medicine & Life Sciences
Bone Marrow Transplantation Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Autologous Transplantation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 370 Citations
  • 10 h-Index
  • 18 Article

A case report of systemic mastocytosis associated with multiple hematologic non–mast cell lineage diseases

Grifoni, F. I., Sciumè, M., Pravettoni, V., Ulivieri, F. M., Muratori, S., Fracchiolla, N. S., Tagliaferri, E., Gianelli, U., Migliorini, A. C., Cro, L., Pacilli, A., Mannelli, F. & Baldini, L., Jan 1 2019, In : Hematological Oncology.

Research output: Contribution to journal › Article

Systemic Mastocytosis
Cell Lineage
Hematologic Neoplasms
Mast-Cell Leukemia
Leukemia, Myelomonocytic, Chronic
1 Citation (Scopus)

Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients

Annaloro, C., Airaghi, L., Giannarelli, D., Mometto, G., Orsatti, A., Saporiti, G., Grifoni, F. I., Baldini, M., Tagliaferri, E., Vincenti, D., Maira, D., Onida, F. & Cortelezzi, A., 2018, In : Annals of Hematology. 97, 12, p. 2471-2478

Research output: Contribution to journal › Article

Hematopoietic Stem Cell Transplantation
Insulin Resistance
Resistin
Transplants
Adipokines
21 Citations (Scopus)

Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis

Del Papa, N., Onida, F., Zaccara, E., Saporiti, G., Maglione, W., Tagliaferri, E., Andracco, R., Vincenti, D., Montemurro, T., Mircoli, L., Vitali, C. & Cortelezzi, A., 2017, In : Bone Marrow Transplantation. 52, 1, p. 53-58

Research output: Contribution to journal › Article

Diffuse Scleroderma
Hematopoietic Stem Cell Transplantation
Lung Volume Measurements
Skin
Control Groups
3 Citations (Scopus)

Quantiferon CMV assay in allogenic stem cell transplant patients

Bono, P., Orlandi, A., Zoccoli, A., Salvatore, A., Annaloro, C., Tagliaferri, E. & Lunghi, G., Jun 1 2016, In : Journal of Clinical Virology. 79, p. 10-11 2 p.

Research output: Contribution to journal › Article

26 Citations (Scopus)

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: A retrospective analysis of the Gruppo Italiano Trapianto di Midollo Osseo

Todisco, E., Ciceri, F., Oldani, E., Boschini, C., Micò, C., Vanlint, M. T., Donnini, I., Patriarca, F., Alessandrino, P. E., Bonifazi, F., Arcese, W., Barberi, W., Marenco, P., Terruzzi, E., Cortelazzo, S., Santarone, S., Proia, A., Corradini, P., Tagliaferri, E., Falcioni, S. & 9 others, Irrera, G., Dallanegra, L., Castagna, L., Santoro, A., Camboni, A., Sacchi, N., Bosi, A., Bacigalupo, A. & Rambaldi, A., Oct 2013, In : Leukemia. 27, 10, p. 2086-2091 6 p.

Research output: Contribution to journal › Article